R&D Systems™ Recombinant Human Hepassocin/FGL1 Fc Chimera Protein

Catalog No.	Quantity
10573HE050	50 μg

Catalog No. 10573HE050 Supplier R&D Systems™ Supplier No. 10573HE050

Description

Measured by its binding ability in a functional ELISA. When Recombinant Human LAG-3 Fc Chimera (Catalog # 2319-L3 ) is coated at 2.5 μg/mL (100 μL/well), the concentration of Recombinant Human Hepassocin/FGL1 Fc Chimera (Catalog # 10573-HE) that produces 50% of the optimal binding response is 0.2-2 μg/mL.

Specifications

• Accession Number: Q08830.3
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 2267
• Molecular Weight (g/mol): M.W.-observed: 60-65 kDa, under reducing conditions, M.W.-theroretical: 61 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human Hepassocin/FGL1 protein MD Human IgG1 (Pro100-Lys330) IEGR Human Hepassocin/FGF1 (Leu23-Ile312) (c-terminus) Accession # Q08830.3 N-terminus C-terminμs
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: FGL1, fibrinogen-like 1, fibrinogen-like protein 1, Fibrinogen-like-protein 1, FREP1, Hepassocin, hepatocellular carcinoma-related sequence, Hepatocyte-derived fibrinogen-related protein 1, HFREP-1, HFREP1MGC12455, HP-041, LFIRE1, LFIRE-1, Liver fibrinogen-related protein 1
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: Hepassocin/FGL1